Eli Lilly & Co. (NYSE:LLY)

Big Pharma Short Sellers Hike Their Bets

Posted: November 27, 2019 at 9:00 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Big Pharma Scares Off Short Sellers

Posted: November 12, 2019 at 8:50 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Big Pharma

Posted: October 25, 2019 at 9:59 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Eli Lilly Just Couldn’t Get It Together in Q3

Posted: October 23, 2019 at 10:25 am

When Eli Lilly and Co. (NYSE: LLY) released its third-quarter financial results before the markets opened on Wednesday, the pharmaceutical giant said that it had $1.48 in earnings per share ...
Read Full Story »

How Biotech and Big Pharma Have Upside Heading Into Earnings

Posted: October 19, 2019 at 6:45 am

Biotech and many of the so-called Big Pharma have been duds in 2019. Despite many FDA approvals and some powerful mergers and royalty deals, the political pressure around drug pricing ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Posted: October 17, 2019 at 9:15 am
Last updated: October 18, 2019 8:16 am

Stocks were indicated to open marginally higher on Thursday as the world appears to have better hopes for a Brexit framework out of Europe. Investors are having to grapple with ...
Read Full Story »

Big Pharma Sees Rising Tide in Short Interest

Posted: October 10, 2019 at 9:40 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Plaque Psoriasis Suffers May Have Better Option After Eli Lilly Study

Posted: October 3, 2019 at 12:10 pm

Eli Lilly and Co. (NYSE: LLY) announced some good news for people suffering moderate to severe plaque psoriasis when it presented at the Fifth Annual Maui Derm NP+PA Fall meeting. ...
Read Full Story »

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

Posted: September 27, 2019 at 10:45 am

With the final quarter of 2019 beginning next Tuesday, many investors are taking a long hard look at their portfolios and trying to make some adjustments. While the end of ...
Read Full Story »

Short Sellers Grow More Selective in Big Pharma

Posted: September 25, 2019 at 9:20 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Big Pharma

Posted: September 12, 2019 at 8:35 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Surprising Reaction to Lung Cancer Study Results

Posted: September 9, 2019 at 12:00 pm

After Eli Lilly and Co. (NYSE: LLY) announced results from its midstage clinical trial for the treatment of lung cancer, its shares dipped on Monday. Specifically, these results come from ...
Read Full Story »

Is NextCure the Next Big Cancer Biotech Every Investor Missed?

Posted: September 5, 2019 at 2:00 pm

The initial public offering class of 2018 and 2019 has been very mixed. There have been some great winners, but there also have been some very well-known unicorns that have ...
Read Full Story »

Big Pharma Sees a Rising Tide in Short Interest

Posted: August 27, 2019 at 8:35 am
Last updated: August 28, 2019 3:42 pm

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Huge Plaque Psoriasis Breakthrough at Eli Lilly

Posted: August 13, 2019 at 11:00 am

Eli Lilly and Co. (NYSE: LLY) shares made a handy gain on Tuesday after the firm announced results from its late-stage study for the treatment of moderate to severe plaque ...
Read Full Story »